Chemoattractant Receptor Homologous to the T Helper 2 Cell (CRTH2) Is Not Expressed in Human Amniocytes and Myocytes

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Sykes, Lynne ^a   Lee, Yun ^a   Khanjani, Shirin ^a   MacIntyre, David A ^a   Yap, Xiao J ^a   Ponnampalam, Sathana ^a   Teoh, Tiong Ghee ^b   Bennett, Phillip R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15DPGJ2; CHEMOATTRACTANT RECEPTOR HOMOLOGOUS TO THE T HELPER 2 CELL; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

AMNION CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOBLOTTING; MOLECULE; MUSCLE CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEINASE INHIBITION; WESTERN BLOTTING;

AMNIOTIC FLUID; ANIMALS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; MUSCLE CELLS; NF-KAPPA B; PEPTIDES; PREGNANCY; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER;

EID: 84870579244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050734     Document Type: Article

References (53)

1. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, et al. (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88: 31-38.
2. Romero R, Mazor M, Munoz H, Gomez R, Galasso M, et al. (1994) The preterm labor syndrome. Ann N Y Acad Sci 734: 414-429.
3. Goldenberg RL, Hauth JC, Andrews WW, (2000) Intrauterine infection and preterm delivery. N Engl J Med 342: 1500-1507.
4. Sykes L, MacIntyre D, Teoh T, Bennett P, (2011) Targeting immune activation in the prevention of preterm labour. European Obstetrics and Gynaecology 6: 100-106.
5. Lappas M, Rice GE (2009) Transcriptional regulation of the processes of human labour and delivery. Placenta 30 Suppl A: S90-95.
6. McCracken SA, Hadfield K, Rahimi Z, Gallery ED, Morris JM, (2007) NF-kappaB-regulated suppression of T-bet in T cells represses Th1 immune responses in pregnancy. Eur J Immunol 37: 1386-1396.
7. Lindstrom TM, Bennett PR, (2005) The role of nuclear factor kappa B in human labour. Reproduction 130: 569-581.
8. Condon JC, Hardy DB, Kovaric K, Mendelson CR, (2006) Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol 20: 764-775.
9. Chapman NR, Europe-Finner GN, Robson SC, (2004) Expression and deoxyribonucleic acid-binding activity of the nuclear factor kappaB family in the human myometrium during pregnancy and labor. J Clin Endocrinol Metab 89: 5683-5693.
10. Allport VC, Pieber D, Slater DM, Newton R, White JO, et al. (2001) Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod 7: 581-586.
11. Lim S, Macintyre DA, Lee YS, Khanjani S, Terzidou V, et al. (2012) Nuclear factor kappa B activation occurs in the amnion prior to labour onset and modulates the expression of numerous labour associated genes. PLoS One 7: e34707.
12. Lappas M, Rice GE, (2007) The role and regulation of the nuclear factor kappa B signalling pathway in human labour. Placenta 28: 543-556.
13. Barnes PJ, Karin M, (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071.
14. Lindstrom TM, Bennett PR, (2005) 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. J Clin Endocrinol Metab 90: 3534-3543.
15. Sykes L, MacIntyre DA, Yap X, Ponnampalam S, Teoh TG, et al. (2012) Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ 12,14- Prostaglandin J2. Mediators of Inflammation 2012: 1-12.
16. Pirianov G, Waddington SN, Lindstrom TM, Terzidou V, Mehmet H, et al. (2009) The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. Endocrinology 150: 699-706.
17. Sawyer N, Cauchon E, Chateauneuf A, Cruz RP, Nicholson DW, et al. (2002) Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 137: 1163-1172.
18. Nagata K, (2003) Crth2. J Biol Regul Homeost Agents 17: 334-337.
19. Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, et al. (1999) Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 162: 1278-1286.
20. Monneret G, Gravel S, Diamond M, Rokach J, Powell WS, (2001) Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98: 1942-1948.
21. Marchese A, Sawzdargo M, Nguyen T, Cheng R, Heng HH, et al. (1999) Discovery of three novel orphan G-protein-coupled receptors. Genomics 56: 12-21.
22. De Fanis U, Mori F, Kurnat RJ, Lee WK, Bova M, et al. (2007) GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood 109: 4343-4350.
23. Nagata K, Hirai H, Tanaka K, Ogawa K, Aso T, et al. (1999) CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 459: 195-199.
24. Nagata K, Hirai H, (2003) The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 69: 169-177.
25. Gallant MA, Samadfam R, Hackett JA, Antoniou J, Parent JL, et al. (2005) Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. J Bone Miner Res 20: 672-681.
26. Zayed N, Afif H, Chabane N, Mfuna-Endam L, Benderdour M, et al. (2008) Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. Arthritis Rheum 58: 3530-3540.
27. Chiba T, Kanda A, Ueki S, Ito W, Kamada Y, et al. (2006) Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway. Int Arch Allergy Immunol 141: 300-307.
28. Colombe L, Michelet JF, Bernard BA, (2008) Prostanoid receptors in anagen human hair follicles. Exp Dermatol 17: 63-72.
29. Gervais FG, Morello JP, Beaulieu C, Sawyer N, Denis D, et al. (2005) Identification of a potent and selective synthetic agonist at the CRTH2 receptor. Mol Pharmacol 67: 1834-1839.
30. Terzidou V, Lee Y, Lindstrom T, Johnson M, Thornton S, et al. (2006) Regulation of the human oxytocin receptor by nuclear factor-kappaB and CCAAT/enhancer-binding protein-beta. J Clin Endocrinol Metab 91: 2317-2326.
31. Venet F, Lepape A, Debard AL, Bienvenu J, Bohe J, et al. (2004) The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock. Clin Immunol 113: 278-284.
32. El-Shazly AE, Moonen V, Mawet M, Begon D, Henket M, et al. (2011) IFN-gamma and TNF-alpha potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. Int Immunopharmacol 11: 1864-1870.
33. Wen SW, Smith G, Yang Q, Walker M, (2004) Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med 9: 429-435.
34. Goldenberg RL, Andrews WW, Hauth JC, (2002) Choriodecidual infection and preterm birth. Nutr Rev 60: S19-25.
35. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, et al. (2007) The fetal inflammatory response syndrome. Clin Obstet Gynecol 50: 652-683.
36. Monneret G, Li H, Vasilescu J, Rokach J, Powell WS, (2002) 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 168: 3563-3569.
37. Helliwell RJ, Keelan JA, Marvin KW, Adams L, Chang MC, et al. (2006) Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. J Clin Endocrinol Metab 91: 597-606.
38. Tsuda H, Michimata T, Sakai M, Nagata K, Nakamura M, et al. (2001) A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy. Clin Exp Immunol 123: 105-111.
39. Michimata T, Tsuda H, Sakai M, Fujimura M, Nagata K, et al. (2002) Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D(2)-mediated manner. Mol Hum Reprod 8: 181-187.
40. Michimata T, Sakai M, Miyazaki S, Ogasawara MS, Suzumori K, et al. (2003) Decrease of T-helper 2 and T-cytotoxic 2 cells at implantation sites occurs in unexplained recurrent spontaneous abortion with normal chromosomal content. Hum Reprod 18: 1523-1528.
41. Gosset P, Bureau F, Angeli V, Pichavant M, Faveeuw C, et al. (2003) Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 170: 4943-4952.
42. Durand M, Gallant MA, de Brum-Fernandes AJ, (2008) Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts. J Bone Miner Res 23: 1097-1105.
43. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, et al. (2000) CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol 30: 2972-2979.
44. Iwasaki M, Nagata K, Takano S, Takahashi K, Ishii N, et al. (2002) Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 119: 609-616.
45. Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M, et al. (2002) Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J Immunol 168: 981-985.
46. Stubbs VE, Schratl P, Hartnell A, Williams TJ, Peskar BA, et al. (2002) Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils. J Biol Chem 277: 26012-26020.
47. Xue L, Gyles SL, Barrow A, Pettipher R, (2007) Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2). Biochem Pharmacol 73: 843-853.
48. Fitzpatrick FA, Wynalda MA, (1983) Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem 258: 11713-11718.
49. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, et al. (2002) 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 277: 10459-10466.
50. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, et al. (2003) Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest 112: 945-955.
51. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, et al. (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103-108.
52. Cernuda-Morollon E, Pineda-Molina E, Canada FJ, Perez-Sala D, (2001) 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J Biol Chem 276: 35530-35536.
53. Narumiya S, Ohno K, Fukushima M, Fujiwara M, (1987) Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei. J Pharmacol Exp Ther 242: 306-311.